Objectives: Renal cell carcinoma is an aggressive malignancy with a high propensity for
both early and metachronous regional and distant metastasis. While surgical resection is the …

Aim: Real life data on the clinical correlates and prognostic value of metastatic sites in
metastatic renal cell carcinoma (RCC) are needed. This parameter was assessed in RCC …

In the US and Europe, clinical practice guidelines for metastatic renal cell carcinoma have
undergone several revisions as a result of the introduction of molecular‐targeted therapies …

For many years immuno (chemo) therapy has been the only therapeutic option for patients
with metastatic renal cell carcinoma. Few patients, however, experienced long-term disease …

Abstract Treatment of renal cell carcinoma has dramatically changed in the past 5 years,
with the approval of six new drugs since 2006. Although treatment algorithms have been …

Metastasectomy in patients with renal cell carcinoma: when a... : Current Opinion in Urology
Metastasectomy in patients with renal cell carcinoma: when and how? : Current Opinion in …

Renal cell carcinoma is one of the common malignancies of the genitourinary tract. In
approximately one third of patients, distant metastases are present at the time of initial …

The treatment of metastatic renal cell carcinoma (mRCC) has been changed by the
introduction of targeted agents. Consideration of individual patient factors, such as previous …

There were only a few options 3 years ago to treat metastatic renal cell carcinoma (mRCC),
a disease with a very poor prognosis. With the approval of targeted therapies for mRCC …

Objective To assess the patterns and predictors of metastatic disease in renal cell carcinoma
(RCC) at the time of diagnosis in a contemporary series. Methods The Surveillance …